RASSF1 and hepatocellular carcinoma: This study aimed to detect serum RASSF1A promoter methylation in patients with HCV-associated liver cirrhosis with and without HCC to evaluate its potential use as a marker for the detection of HCC in patients with chronic hepatitis C infection.